BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20146698)

  • 21. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.
    Halliday GM; McCann H
    Exp Neurol; 2008 Jan; 209(1):12-21. PubMed ID: 17706644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?
    Halliday G; McCann H; Shepherd C
    Expert Rev Neurother; 2012 Jun; 12(6):673-86. PubMed ID: 22650170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An autopsy case of senile dementia with pathological features of Parkinson's disease].
    Oshima K; Tsuchiya K; Iritani S; Niizato K; Akiyama H; Ikeda K; Arai H
    No To Shinkei; 2004 Jul; 56(7):603-6. PubMed ID: 15379289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A not entirely benign procedure: progression of Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2008 Apr; 115(4):379-84. PubMed ID: 18320198
    [No Abstract]   [Full Text] [Related]  

  • 31. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
    Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
    Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
    Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
    Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dementia with Lewy bodies.
    Lennox GG; Lowe JS
    Baillieres Clin Neurol; 1997 Apr; 6(1):147-66. PubMed ID: 9426873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic contributions to Parkinson's disease.
    Huang Y; Cheung L; Rowe D; Halliday G
    Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Jellinger KA
    Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163
    [No Abstract]   [Full Text] [Related]  

  • 39. [An autopsy case of Parkinson's disease associated clinically with dementia terminating in akinetic mutism and pathologically with multiple Lewy's Bodies in the cerebral cortex].
    Okeda R; Kayano T; Funata N; Kojima T; Miki M; Iwama H
    No To Shinkei; 1982 Aug; 34(8):761-7. PubMed ID: 6289855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
    Braak H; Sastre M; Del Tredici K
    Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.